Computer Aided Detection (CAD): A US and European Market Report
San Jose, California (PRWEB) February 04, 2015
Follow us on LinkedIn – The dramatic rise in the use of digital imaging modalities is resulting in significant increases in the volume of image-data generated. CAD technology enables accurate analysis of clinical imaging data with minimal detection errors. Computers and relevant software have been playing pivotal roles in the acquisition, storage, and distribution of images captured from imaging modalities (such as X-ray, Ultrasound diagnostics, and MRI).The use of CAD is proven to increase cancer detection in early stages. Advancements in digital imaging techniques are paving the way for enhanced adoption of CAD in imaging. Major advancements include ease of integration with imaging modalities from multiple vendors, improved display aspects, manipulability of images, image viewing, and management speed. Efforts are underway to expand the utility of CAD technology to 3D imaging through tomosynthesis. A number of vendors are developing tomosynthesis CAD products for analysis of 3D data sets.
Breast cancer detection continues to dominate the market, supported by the rising use of CAD in conjunction with ultrasound, mammography, and MRI. Technology advancements are encouraging the use of the technology in colon, lung, prostrate, and liver cancer diagnosis. Use of CAD in lung and colon cancer detection is gaining momentum, driven by the availability of new innovative products. Despite gaining popularity over the years, CAD continues to remain the second choice among radiologists after mammography. However, with the inclusion of patient context element, adoption is poised grow in the coming years. Patient context requires the integration of vital patient information, such as medical history, and details of prior diagnoses and mammograms.
As stated by the new market research report on Computer Aided Detection (CAD), the United States represents the largest market worldwide. The country is also projected to be the fastest growing market with a compounded annual growth rate of 9.6% over the analysis period. The US FDA’s release of final guidance providing clarity to manufacturers on clinical study requirements, and approval of CAD devices and software, is expected to foster the development of new products in the coming years. Meanwhile, the focus on early detection is expected to increase the significance of CAD technology in Europe.
Major players covered in the report include EDDA Technology Inc., Hologic Inc., iCAD Inc., Invivo Corp., Merge Healthcare Inc., Riverain Technologies, Salient Imaging Inc., Siemens Healthcare, and VuCOMP Inc., among others.
The research report titled “Computer Aided Detection (CAD): A US and European Market Report” announced by Global Industry Analysts Inc., provides a comprehensive review of trends, growth drivers, restraints, market share, size and demand projections and forecasts. Major geographic regions covered include the United States and Europe. Application segments analyzed in the report include Breast, Chest, and Others. The report also offers coverage on mergers, acquisitions, product launches and other strategic industry activities of major global and regional players.
For more details about this comprehensive market research report, please click here
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/
Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.